Roberto Merenda

Venice, 30122, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Ill Fate of Rectal Mucinous Adenocarcinoma: A Defect in Immunosurveillance or a Mucin Coating Effect?-The IMMUNOREACT 20 Study.

Ill Fate of Rectal Mucinous Adenocarcinoma: A Defect in Immunosurveillance or a Mucin Coating Effect?-The IMMUNOREACT 20 Study.

Journal: Cancers

Published: May 12, 2026

IMMUNOREACT 4: Peritumoral Microenvironment Associated with Anastomotic Leaks After Surgery for Rectal Cancer.

IMMUNOREACT 4: Peritumoral Microenvironment Associated with Anastomotic Leaks After Surgery for Rectal Cancer.

Journal: Cancers

Published: December 23, 2025

IMMUNOREACT 8: Immune markers of local tumor spread in patients undergoing transanal excision for clinically N0 rectal cancer.

IMMUNOREACT 8: Immune markers of local tumor spread in patients undergoing transanal excision for clinically N0 rectal cancer.

Journal: Surgery

Published: June 10, 2024

IMMUNOREACT 9 metachronous rectal cancers have high HLA-ABC expression on healthy epithelium but a lower infiltration of CD3+ T cells than primary lesions.

IMMUNOREACT 9 metachronous rectal cancers have high HLA-ABC expression on healthy epithelium but a lower infiltration of CD3+ T cells than primary lesions.

Journal: Scientific reports

Published: February 18, 2024

IMMUNOREACT 7: Regular aspirin use is associated with immune surveillance activation in colorectal cancer.

IMMUNOREACT 7: Regular aspirin use is associated with immune surveillance activation in colorectal cancer.

Journal: Cancer

Published: September 06, 2023

IMMUNOREACT 6: weak immune surveillance characterizes early-onset rectal cancer.

IMMUNOREACT 6: weak immune surveillance characterizes early-onset rectal cancer.

Journal: The British journal of surgery

Published: February 17, 2023

IMMUNOREACT 5: female patients with rectal cancer have better immune editing mechanisms than male patients - a cohort study.

IMMUNOREACT 5: female patients with rectal cancer have better immune editing mechanisms than male patients - a cohort study.

Journal: International journal of surgery (London, England)

Published: September 06, 2022

Lessons learned from 227 biological meshes used for the surgical treatment of ventral abdominal defects.

Lessons learned from 227 biological meshes used for the surgical treatment of ventral abdominal defects.

Journal: Hernia : the journal of hernias and abdominal wall surgery

Published: March 26, 2018

Showing 1-8 of 8

Last Updated: 09/26/2026